Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation
about
Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartumHistory of clinical transplantationImportance of liver biopsy findings in immunosuppression management: biopsy monitoring and working criteria for patients with operational toleranceThe dichotomous functions of passenger leukocytes in solid-organ transplantationThe unfinished legacy of liver transplantation: emphasis on immunology.Transplantation tolerance, microchimerism, and the two-way paradigm.Immunity and tolerance are related, and governed by antigen migration and localizationAcquired immunologic tolerance: with particular reference to transplantationProposed mechanisms of transfusion-induced immunomodulationImmune "tolerance profiles" in donor bone marrow infused kidney transplant patients using multiple ex vivo functional assays.Allografts surviving for 26 to 29 years following living-related kidney transplantation: analysis by light microscopy, in situ hybridization for the Y chromosome, and anti-HLA antibodies.Hematopoietic progenitor cell content of vertebral body marrow used for combined solid organ and bone marrow transplantation.A clinical trial combining donor bone marrow infusion and heart transplantation: intermediate-term resultsBone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation.Documentation in bone-marrow-augmented organ recipients of the presence of dendritic cell progenitors of donor originCombined simultaneous kidney/bone marrow transplantationMicrochimerism, dendritic cell progenitors and transplantation toleranceIdentification of donor-derived dendritic cell progenitors in bone marrow of spontaneously tolerant liver allograft recipients.Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptancePerioperative donor bone marrow infusion augments chimerism in heart and lung transplant recipients.Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation.Murine liver allograft transplantation: tolerance and donor cell chimerismNew immunosuppressive drugs: mechanistic insights and potential therapeutic advancesMatching and the black recipientRecent advances in renal interstitial fibrosis and tubular atrophy after kidney transplantation.Spontaneous and iatrogenically augmented leukocyte chimerism in organ transplant recipientsEpstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders.Effects of donor bone marrow infusion in clinical lung transplantation.The current status of hepatic transplantation at the University of PittsburghWeaning of immunosuppression in long-term recipients of living related renal transplants: a preliminary study.The birth of clinical organ transplantation.The superiority of tacrolimus in renal transplant recipients -- the Pittsburgh experience.The two-way paradigm of transplantation immunology.Xenobiotics, chimerism and the induction of tolerance following organ transplantation.The lost chord: microchimerism and allograft survival.Frequent achievement of a drug-free state after orthotopic liver transplantation.The future of transplantation: with particular reference to chimerism and xenotransplantationThe role of HLA typing in clinical kidney transplants: 30 years later. The blind-folding of HLA matchingAugmentation of natural chimerism with donor bone marrow in orthotopic liver recipients.HLA matching and the point system.
P2860
Q24567463-5DE603A7-BEE7-49D3-AD7B-9B876716B75BQ24596303-4A49B12C-103C-434F-AB68-99E692BFCF87Q27026283-8B787E42-1348-44DF-B36E-C5B6F4C37FF8Q28290158-98C63A3C-3497-4B63-B12F-2CC863AC8665Q30352760-4CEC3F6F-E927-48E9-9E9C-F8D61C709A55Q33534180-90469D8B-CD44-426B-8BD3-EF881020C970Q33542774-3427D58B-96B1-44CC-9F56-E01D2A75D625Q33567138-0B511FCD-1548-4941-B445-7E40D6DB8868Q33726355-F6575FD5-C081-46B1-9117-4688C2FF8DD0Q33867234-439A14C4-B9BA-48A4-8F0F-4FF6E4BD6091Q34178614-8DB2409A-6DB1-44FF-9437-8FDAA0E5FB37Q34219104-E50B0C43-EE32-4D02-8D8B-7C1B2D17D2F7Q34219866-EA3D2805-3F1B-4EBA-AA93-B7A70090AB35Q34232532-45816D22-19F1-4660-BE17-6A02BCE02DF4Q34232581-F68C0A3A-B707-4D46-998F-D9D6160D0131Q34232727-F8E559F4-B85C-4721-AE11-34F83D6B4753Q34239907-5E84BC72-151B-45AC-9375-0D36E69C62A5Q34240562-53078954-CAE6-4C7F-A11D-2CA30B43A601Q34241674-BF1899B8-C6F5-4824-9878-770D5FF02A3AQ34256648-3E8D7FDB-59C5-488A-8408-6C57EBCD2043Q34257352-2F9FC8D9-603C-498C-A390-459EFCFE4DDFQ34275121-CA2C45B4-D3FA-4F5B-867B-1A7BB79B515EQ34275358-F2D38407-56C7-491B-A569-71D17917382CQ34286412-FD407117-F888-4415-BCE8-B356614AA8C6Q34289498-F0C705A7-E478-4C4C-94C3-D91937BDE3E1Q34289617-9BAF5A21-1F9B-405C-B1D2-459D94F532D8Q34302121-19C4618A-081C-460B-9480-09D0701F8154Q34312228-E165B2C4-3571-4028-99C9-22D9F78E72E6Q34330449-397CFC63-C69F-4563-BB23-D76F7F45F237Q34333994-6B8B7C32-E4ED-4E5F-B86C-AA31E0C72DDBQ34340940-540FB5C3-BDBB-480E-995F-A87A35D2CB5EQ34346715-31E4225F-D920-46D1-A916-E5C3F394A53FQ34346915-6AFBEC96-7268-4854-BD13-10EC604805CDQ34357964-43D77821-5AED-4399-8B26-4D728DC7A2ACQ34359678-3AA2E218-5B93-4741-9F26-7789C9C576F5Q34363655-3142A1F6-C9AD-4765-AE5F-08FD3AAE1ED4Q34363671-49916D9E-071F-4B08-AFD8-4701EF0DE158Q34369476-41C7A324-FEC9-4E58-9900-8A9F88F4391CQ34383171-24308FB1-69FE-432B-9809-6A04F5F64A20Q34396748-23036CEA-0339-48E0-B376-B4ECADD57A69
P2860
Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation
description
1993 nî lūn-bûn
@nan
1993 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Chimerism and donor-specific n ...... ter kidney allotransplantation
@ast
Chimerism and donor-specific n ...... ter kidney allotransplantation
@en
Chimerism and donor-specific n ...... ter kidney allotransplantation
@nl
type
label
Chimerism and donor-specific n ...... ter kidney allotransplantation
@ast
Chimerism and donor-specific n ...... ter kidney allotransplantation
@en
Chimerism and donor-specific n ...... ter kidney allotransplantation
@nl
prefLabel
Chimerism and donor-specific n ...... ter kidney allotransplantation
@ast
Chimerism and donor-specific n ...... ter kidney allotransplantation
@en
Chimerism and donor-specific n ...... ter kidney allotransplantation
@nl
P2093
P2860
P50
P1433
P1476
Chimerism and donor-specific n ...... ter kidney allotransplantation
@en
P2093
P Terasaki
W A Rudert
P2860
P304
P356
10.1097/00007890-199306000-00012
P577
1993-06-01T00:00:00Z